Enhanced menadione cytotoxicity in platelets isolated from streptozotocin-induced diabetic rats

Thrombosis Research

Volumn 111, Issue 3, 2003, Pages 179-183

  Bae, Ok Nam ^a   Lee, Joo Young ^a   Chung, Ga Young ^a   Chung, Seung Min ^a   Lee, Moo Yeol ^a   Yun, Yeo Pyo ^b   Kim, Young Chul ^a   Moon, Chang Kiu ^a   Chung, Jin Ho ^a  

^a Seoul National University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Diabetes; Menadione cytotoxicity; Oxidative stress; Platelets

Indexed keywords

FREE RADICAL; GLUTATHIONE; LACTATE DEHYDROGENASE; MENADIONE; SEROTONIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL ISOLATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; RAT; RAT STRAIN; SEROTONIN RELEASE; THROMBOCYTE; THROMBOSIS; TIME;

EID: 0348110563     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.003     Document Type: Article

References (26)

1. Mandel H.G., Cohn V.H. Vitamin K. Gilman A.G., Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 1980;1592-1596 Macmillan, New York.
2. Thor H., Smith M.T., Hartzell P.et al. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:1982;12419-12425.
3. Monks T.J., Hanzlik R.P., Cohen G.M.et al. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112:1992;2-16.
4. Kim K.A., Lee J.Y., Park K.S.et al. Mechanism of menadione-induced cytotoxicity in rat platelets. Toxicol. Appl. Pharmacol. 138:1996;12-19.
5. Kroll M.H., Schafer A.I. Biochemical mechanisms of platelet activation. Blood. 74:1989;1181-1195.
6. Willerson J.T., Golino P., Eidt J.et al. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation. 80:1989;198-205.
7. Porte D. Jr., Schwartz M.W. Diabetes complications: why is glucose potentially toxic? Science. 272:1996;699-700.
8. Bierman E.L. Atherogenesis in diabetes. Arterioscler. Thromb. 12:1992;647-656.
9. Winocour P.D. Platelets, vascular disease, and diabetes mellitus. Can. J. Physiol. Pharmacol. 72:1994;295-303.
10. Winocour P.D. Platelet abnormalities in diabetes mellitus. Diabetes. 41(Suppl. 2):1992;26-31.
11. Thomas G., Skrinska V., Lucas F.V.et al. Platelet glutathione and thromboxane synthesis in diabetes. Diabetes. 34:1985;951-954.
12. Catella-Lawson F., FitzGerald G.A. Oxidative stress and platelet activation in diabetes mellitus. Diabetes Res. Clin. Pract. 30(Suppl. l):1996;13-18.
13. Mazzanti L., Mutus B. Diabetes-induced alterations in platelet metabolism. Clin. Biochem. 30:1997;509-515.
14. Keaney J.F. Jr., Loscalzo J. Diabetes, oxidative stress, and platelet activation. Circulation. 99:1999;189-191.
15. Cohen I., Burk D., Fullerton R.J.et al. Nonenzymatic glycation of human blood platelet proteins. Thromb. Res. 55:1989;341-349.
16. Bergmeyer H.U., Bernt E., Hess B. Lactate dehydrogenase. Bergmeyer H.U., Bermeyer J., Bral M. Methods in Enzymatic Analysis. 1965;736 Academic Press, New York.
17. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
18. Holmsen H., Dangelmaier C.A. Measurement of secretion of serotonin. Hawiger J. Methods in Enzymology. Platelets: Receptors, Adhesion, Secretion. vol. 169:1989;205-210 Academic Press, New York.
19. Muruganandam A., Drouillard C., Thibert R.J.et al. Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Thromb. Res. 67:1992;385-397.
20. Yoshida K., Hirokawa J., Tagami S.et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia. 38:1995;201-210.
21. Laight D.W., Carrier M.J., Anggard E.E. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 47:2000;457-464.
22. Cho Y.S., Kim M.J., Lee J.Y.et al. The role of thiols in protecting against simultaneous toxicity of menadione to platelet plasma and intracellular membranes. J. Phamacol. Exp. Ther. 280:1997;1335-1340.
23. Bryant R.W., Simon T.C., Bailey J.M. Role of hexose monophosphate shunt in the platelet lipoxygenase pathway. J. Biol. Chem. 257:1982;14937-14943.
24. Hill T.D., White J.G., Rao G.H. Role of glutathione peroxidase in human platelet arachidonic acid metabolism. Prostaglandins. 38:1989;21-32.
25. Bosia A., Spangenberg P., Ghogo D.et al. Effect of glutathione depletion by 1-chloro-2,4-dinitrobenzene on human platelet aggregation, arachidonic acid oxidative metabolic and cytoskeleton proteins. Thromb. Res. 37:1985;423-434.
26. Lee J.Y., Lee M.Y., Chung S.M.et al. Chemically induced platelet lysis causes vasoconstriction by release of serotonin. Toxicol. Appl. Pharmacol. 149:1998;235-242.